iCAD, Inc. (ICAD)
3.870
+0.140 (3.75%)
Inactive · Last trade price on Jul 16, 2025
Catalent Employees
iCAD, Inc. had 66 employees as of December 31, 2024. The number of employees decreased by 3 or -4.35% compared to the previous year.
Employees
66
Change (1Y)
-3
Growth (1Y)
-4.35%
Revenue / Employee
$295,879
Profits / Employee
-$79,197
Market Cap
105.59M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 66 | -3 | -4.35% |
| Dec 31, 2023 | 69 | -40 | -36.70% |
| Dec 31, 2022 | 109 | -28 | -20.44% |
| Dec 31, 2021 | 137 | 23 | 20.18% |
| Dec 31, 2020 | 114 | -24 | -17.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
ICAD News
- 2 months ago - ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD - Business Wire
- 2 months ago - iCAD Reports Financial Results for First Quarter Ended March 31, 2025 - GlobeNewsWire
- 4 months ago - iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer - GlobeNewsWire
- 4 months ago - iCAD, Inc. (ICAD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024 - GlobeNewsWire
- 5 months ago - iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America - GlobeNewsWire
- 5 months ago - Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025 - GlobeNewsWire
- 5 months ago - iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025 - GlobeNewsWire